At our West Palm Beach clinic, care is medical and measured: gradual dose titration, side-effect mitigation, and real-world nutrition coaching
It is important to stay informed, communicate openly with your healthcare team, and take proactive steps to manage your health effectively
The SELECT trial showed that semaglutide reduced major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in adults with obesity and established cardiovascular disease, without requiring a diabetes diagnosis. The FLOW trial showed kidney benefits with semaglutide use in patients with type 2 diabetes and chronic kidney disease. Improvements in hard clinical outcomes like cardiac events, kidney disease, and death are commonly observed with GLP-1 use, and are due to both the direct effects of treating the obesity, and indirect effects of the medications themselves
Meister D, Bode J, et al
half of former users expect to use again
Always check with your healthcare provider for the best dose for you